These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 28598117

  • 1. [Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.].
    Jing H, Liu XY, Chen YL, Bai LP, Zheng A.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):878-882. PubMed ID: 28598117
    [Abstract] [Full Text] [Related]

  • 2. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I, Cacsire Castillo-Tong D, Vergote I, Ignat I, Stanske M, Vanderstichele A, Ganapathi RN, Glajzer J, Kulbe H, Trillsch F, Mustea A, Kreuzinger C, Benedetti Panici P, Gourley C, Gabra H, Kessler M, Sehouli J, Darb-Esfahani S, Braicu EI.
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
    Tao Y, Li H, Huang R, Mo D, Zeng T, Fang M, Li M.
    Cell Physiol Biochem; 2018 Jul; 46(4):1716-1726. PubMed ID: 29730663
    [Abstract] [Full Text] [Related]

  • 4. Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases.
    Stemberger-Papić S, Vrdoljak-Mozetic D, Ostojić DV, Rubesa-Mihaljević R, Krigtofić I, Brncić-Fisher A, Kragević M, Eminović S.
    Coll Antropol; 2015 Sep; 39(3):745-53. PubMed ID: 26898076
    [Abstract] [Full Text] [Related]

  • 5. [Expression and Clinical Significance of Numb and P53 Proteins in Epithelial Ovarian Carcinoma].
    Xu M, He HJ, Zhang H, Wang A, Chen J.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):76-80. PubMed ID: 28612563
    [Abstract] [Full Text] [Related]

  • 6. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
    Kapucuoğlu N, Bozkurt KK, Başpınar Ş, Koçer M, Eroğlu HE, Akdeniz R, Akçil M.
    Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.
    Yu L, Zhu B, Wu S, Zhou L, Song W, Gong X, Wang D.
    Diagn Pathol; 2017 Mar 02; 12(1):23. PubMed ID: 28253891
    [Abstract] [Full Text] [Related]

  • 8. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
    Mizuno T, Suzuki N, Makino H, Furui T, Morii E, Aoki H, Kunisada T, Yano M, Kuji S, Hirashima Y, Arakawa A, Nishio S, Ushijima K, Ito K, Itani Y, Morishige K.
    Gynecol Oncol; 2015 May 02; 137(2):299-305. PubMed ID: 25541259
    [Abstract] [Full Text] [Related]

  • 9. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N, Choung HK, Lee MJ, Khwarg SI, Kim JE.
    Invest Ophthalmol Vis Sci; 2015 Feb 24; 56(3):1813-9. PubMed ID: 25711631
    [Abstract] [Full Text] [Related]

  • 10. Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.
    Ayub TH, Keyver-Paik MD, Debald M, Rostamzadeh B, Thiesler T, Schröder L, Barchet W, Abramian A, Kaiser C, Kristiansen G, Kuhn W, Kübler K.
    Oncotarget; 2015 Jun 30; 6(18):16437-48. PubMed ID: 25999351
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.
    Mansour SF, Atwa MM.
    Asian Pac J Cancer Prev; 2015 Jun 30; 16(17):7491-6. PubMed ID: 26625750
    [Abstract] [Full Text] [Related]

  • 12. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K, Sentani K, Oue N, Yasui W.
    Pathol Int; 2012 Feb 30; 62(2):112-9. PubMed ID: 22243781
    [Abstract] [Full Text] [Related]

  • 13. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
    Roudi R, Korourian A, Shariftabrizi A, Madjd Z.
    Cancer Invest; 2015 Feb 30; 33(7):294-302. PubMed ID: 26046383
    [Abstract] [Full Text] [Related]

  • 14. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
    Liu W, Wu L, Shen XM, Shi LJ, Zhang CP, Xu LQ, Zhou ZT.
    Int J Cancer; 2013 Feb 15; 132(4):868-74. PubMed ID: 22782852
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.
    Zhou Y, Chen D, Qi Y, Liu R, Li S, Zou H, Lan J, Ju X, Jiang J, Liang W, Shen Y, Pang L, Li F.
    Oncol Rep; 2017 Jun 15; 37(6):3351-3360. PubMed ID: 28498445
    [Abstract] [Full Text] [Related]

  • 16. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
    Ortiz RC, Lopes NM, Amôr NG, Ponce JB, Schmerling CK, Lara VS, Moyses RA, Rodini CO.
    J Oral Pathol Med; 2018 Sep 15; 47(8):740-747. PubMed ID: 29791975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
    Shien K, Toyooka S, Ichimura K, Soh J, Furukawa M, Maki Y, Muraoka T, Tanaka N, Ueno T, Asano H, Tsukuda K, Yamane M, Oto T, Kiura K, Miyoshi S.
    Lung Cancer; 2012 Jul 15; 77(1):162-7. PubMed ID: 22387005
    [Abstract] [Full Text] [Related]

  • 19. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
    Liebscher CA, Prinzler J, Sinn BV, Budczies J, Denkert C, Noske A, Sehouli J, Braicu EI, Dietel M, Darb-Esfahani S.
    Hum Pathol; 2013 Aug 15; 44(8):1465-71. PubMed ID: 23465277
    [Abstract] [Full Text] [Related]

  • 20. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
    Lan J, Huang B, Liu R, Ju X, Zhou Y, Jiang J, Liang W, Shen Y, Li F, Pang L.
    Int J Clin Exp Pathol; 2015 Aug 15; 8(10):12621-33. PubMed ID: 26722452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.